ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................*JDIM360 Ver 2.40 (30 Jan 2013) - 2999001/02139484CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120130821W173deBibliographieenBibliographyfrBibliographieEP08742677.1200804092009102820100607enenen922899 P20070410US2013082120133420100106201001201307172013292013012820130821201334A61K 31/517 20060101AFI20081030BHEP A61K 31/519 20060101ALI20081030BHEP A61K 45/06 20060101ALI20081030BHEP A61K 31/282 20060101ALI20081030BHEP A61K 31/337 20060101ALI20081030BHEP A61K 31/4745 20060101ALI20081030BHEP A61P 35/00 20060101ALI20081030BHEP deVERFAHREN ZUR KREBSBEHANDLUNG MIT PI3K-ALPHA-PYRIDOPYRIMIDONHEMMERNenMETHODS OF TREATING CANCER USING PYRIDOPYRIMIDINONE INHIBITORS OF PI3K ALPHAfrMÉTHODES DE TRAITEMENT DU CANCER À L'AIDE D'INHIBITEURS DE PI3K ALPHA À BASE DE PYRIDOPYRIMIDINONEWO-A-2004/006846WO-A-2005/105801WO-A-2007/044698WO-A-2008/021389US-A1- 2004 009 99312172484.320120618LAMB, Peter814 Mandana BlvdOakland, California 94610USMATTHEWS, David2 Balceta AvenueSan Francisco, California 94127USExelixis, Inc.101288191P114041.EP.01210 East Grand AvenueSouth San Francisco, CA 94080USMain, Malcolm Charles101082862Murgitroyd & Company Immeuble Atlantis 55 Allee Pierre Ziller06560 Valbonne - Sophia AntipolisFRATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMTNLNOPLPTROSESISKTRAL20091028BA20091028MK20091028RS20091028US200800457320080409enWO20081241612008101620084220100106201001